The writing of each chapter of the guidelines was led by one main author and one or two co-
authors (see below) and extensively supported by Elinor Chisholm and Ramona Ludolph …

Introduction Meningococcal colonization, or carriage, can progress to invasive
meningococcal disease, a serious public health concern, with rapid progression of disease …

Vaccination of at-risk populations against Neisseria meningitidis is an important strategy to
prevent invasive meningococcal disease (IMD). The objective of this study was to …

Invasive meningococcal disease (IMD) remains a major cause of mortality and morbidity in
children worldwide. A systemic review in PubMed and Cochrane Controlled Trials Register …

Background Serogroup causing invasive meningococcal disease (IMD) can change
abruptly, as it occurred in Chile when serogroup predominance switched from MenB to …

Neisseria meningitidis, a gram-negative diplococcus, is typically an asymptomatic coloniser
of the oropharynx and nasopharynx. Passage of N. meningitidis into the bloodstream can …

Neisseria meningitidis serogroup W has emerged as an increasingly common cause of
invasive meningococcal disease worldwide; the average case-fatality rate is 10%. In 2017 …

Abstract MenB-FHbp (Trumenba®; bivalent rLP2086) is a meningococcal serogroup B
vaccine containing 2 variants of the recombinant lipidated factor H binding protein (FHbp) …

Background The National Surveillance for Invasive Meningococcal Disease (IMD) initiative
started in Japan in April 2013. Multiple international mass gathering events have since been …

Purpose Eculizumab, a drug that blocks activation of the terminal complement pathway, is
useful in the treatment of several rare diseases. However, eculizumab-related …